Bronson Battle Creek Offers New Procedure to Treat Incontinence - Bronson Healthcare
Share

Published on August 07, 2014

Battle Creek, Mich. – Bronson Battle Creek recently introduced Interstim Therapy, an innovative new approach to help patients who struggle with bladder and bowel control.  The procedure called sacral neuromodulation is minimally invasive and doctors at Bronson Center for Colon and Rectal Diseases are finding it to be highly effective in treating fecal incontinence.   According to a National Institutes of Health-funded study, more than 18 million Americans suffer from bowel incontinence problems, and as a result they often struggle with everyday activities, such as traveling or spending time with friends and family. Fecal incontinence is more common in adults, predominately women, and it is not a normal part of aging. It can be caused by a variety of factors, including damage to the nerves or muscles in the rectum from trauma such as childbirth, or other pelvic health disorders.

Cheryl Rogers was one of those people who thought her age was the reason for her fecal incontinence. When she began experiencing unbearable pain, she learned of the new procedure at Bronson Battle Creek. Rogers says, “I was just elated. I can’t believe how modern medicine has expanded.” To make sure her body would respond to the treatment, Cheryl had the opportunity to wear a monitor during a trial evaluation period. With no side effects from the monitor, she was able to have surgery two weeks later. Read her whole story here.

The implantable InterStim system uses mild electrical stimulation of the sacral nerves to influence the behavior of the pelvic floor muscles and bowel. As a result, the therapy significantly reduces fecal incontinent episodes for many patients.  InterStim Therapy is the only bowel control treatment option that allows patients and physicians to determine probable success of the therapy through a test stimulation procedure prior to committing to long-term therapy.

“Bowel control problems can significantly impair a patient’s quality of life, and many patients are too embarrassed or uncomfortable to talk about the problem with their physician,” said Mahesh Karamchandani, M.D., of Bronson Center for Colon and Rectal Diseases, one of the first to offer the new therapy in this area.  “Until now, there have been limited treatment options for people with fecal incontinence who don’t respond to conservative therapies. InterStim Therapy for Bowel Control gives these individuals hope for living a more normal life.”

 

For more information, call Bronson Colon & Rectal Diseases – Battle Creek at (269) 441-1771.